Welcome to LookChem.com Sign In|Join Free

CAS

  • or

114132-26-2

Post Buying Request

114132-26-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

114132-26-2 Usage

Uses

Cyclopropylmethanesulfonyl Chloride is used in the discovery of novel aminotetralines and aminochromanes as selective and competitive glycine transporter 1 (GlyT1) inhibitors.

Check Digit Verification of cas no

The CAS Registry Mumber 114132-26-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,4,1,3 and 2 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 114132-26:
(8*1)+(7*1)+(6*4)+(5*1)+(4*3)+(3*2)+(2*2)+(1*6)=72
72 % 10 = 2
So 114132-26-2 is a valid CAS Registry Number.

114132-26-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name Cyclopropylmethanesulfonyl chloride

1.2 Other means of identification

Product number -
Other names cyclopropylmethylsulfonyl chloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:114132-26-2 SDS

114132-26-2Upstream product

114132-26-2Relevant articles and documents

Substituted heteroaryl compounds and composition thereof, and applicaitons of compounds and composition

-

Paragraph 0790; 0791; 1109; 1110, (2017/07/31)

The invention provides substituted heteroaryl compounds and a composition thereof, and applicaitons of the compounds and the composition. The compounds are compounds represented by the formula (I) or the formula (II) or stereoisomers, tautomers, nitrogen oxides, solvates, metabolites, pharmaceutically acceptable salts or prodrugs of the compounds represented by the formula (I) or the formula (II). The invention also provides the pharmaceutical composition comprising the compounds; the compounds and the pharmaceutical composition can adjust the activity of protein kinase, and are used for prevention, processing, treatment and remission of diseases or disorders mediated by the protein kinase.

Fused ring compound

-

Page/Page column 71, (2008/12/07)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 114132-26-2